These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 15142388)

  • 1. Pharmacological treatment of adolescent major depression.
    Cohen D; Gerardin P; Mazet P; Purper-Ouakil D; Flament MF
    J Child Adolesc Psychopharmacol; 2004; 14(1):19-31. PubMed ID: 15142388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of child and adolescent depression.
    Moreno C; Roche AM; Greenhill LL
    Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):977-98, x. PubMed ID: 16952771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of pharmacotherapy of major depression in children and adolescents.
    Ambrosini PJ
    Psychiatr Serv; 2000 May; 51(5):627-33. PubMed ID: 10783181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
    Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
    Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of depression in children and adolescents.
    Findling RL; Reed MD; Blumer JL
    Paediatr Drugs; 1999; 1(3):161-82. PubMed ID: 10937449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antidepressants to treat depression in children and adolescents.
    Cheung AH; Emslie GJ; Mayes TL
    CMAJ; 2006 Jan; 174(2):193-200. PubMed ID: 16415467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in antidepressant therapy in special populations.
    Hayes D
    Am J Manag Care; 2004 Jul; 10(6 Suppl):S179-85. PubMed ID: 15354675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for major depression in children and adolescents.
    Wagner KD
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):819-26. PubMed ID: 15908090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression.
    Findling RL; McNamara NK; Stansbrey RJ; Feeny NC; Young CM; Peric FV; Youngstrom EA
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):131-45. PubMed ID: 16553534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does increasing dose improve efficacy in patients with poor antidepressant response: a review.
    Corruble E; Guelfi JD
    Acta Psychiatr Scand; 2000 May; 101(5):343-8. PubMed ID: 10823292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Childhood and adolescent depression].
    Mikami K; Matsumoto H
    Nihon Rinsho; 2007 Sep; 65(9):1679-83. PubMed ID: 17876994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder in adolescence: a brief review of the recent treatment literature.
    Milin R; Walker S; Chow J
    Can J Psychiatry; 2003 Oct; 48(9):600-6. PubMed ID: 14631880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of depression in women with breast cancer: a systematic review.
    Toftegård Andersen L; Voigt Hansen M; Rosenberg J; Gögenur I
    Breast Cancer Res Treat; 2013 Oct; 141(3):325-30. PubMed ID: 24077731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.